PINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 5.364
EU - Europa 2.739
AS - Asia 1.465
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 7
OC - Oceania 6
Totale 9.607
Nazione #
US - Stati Uniti d'America 5.349
CN - Cina 805
UA - Ucraina 780
IT - Italia 558
DE - Germania 340
HK - Hong Kong 331
FI - Finlandia 269
PL - Polonia 222
IE - Irlanda 209
GB - Regno Unito 191
IN - India 182
SG - Singapore 58
VN - Vietnam 53
FR - Francia 50
SE - Svezia 44
BE - Belgio 39
CA - Canada 15
MU - Mauritius 13
TR - Turchia 13
EU - Europa 12
RU - Federazione Russa 8
AU - Australia 6
MK - Macedonia 6
ID - Indonesia 5
JP - Giappone 5
NL - Olanda 5
RO - Romania 5
NO - Norvegia 4
CY - Cipro 3
GR - Grecia 3
IR - Iran 3
AR - Argentina 2
BR - Brasile 2
CL - Cile 2
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
IM - Isola di Man 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 9.607
Città #
Fairfield 600
Jacksonville 584
Woodbridge 548
Ashburn 463
Chandler 449
Houston 382
Princeton 364
Hong Kong 330
New York 291
Wilmington 262
Ann Arbor 234
Cambridge 231
Seattle 226
Warsaw 221
Dublin 186
Brescia 172
Nanjing 170
Helsinki 164
Nanchang 90
Beijing 73
Des Moines 73
Verona 60
San Diego 57
Dong Ket 53
Shenyang 53
Changsha 49
Hebei 49
Jinan 46
Lancaster 46
Shanghai 44
Milan 40
Brussels 39
Jiaxing 37
Tianjin 36
Washington 32
London 25
Hangzhou 24
Kunming 22
San Francisco 22
Pune 17
Trento 17
Zhengzhou 17
Menlo Park 15
Azzano 14
Haikou 14
Lanzhou 12
Guangzhou 11
Taizhou 11
Dearborn 10
Rozzano 10
New Bedfont 9
Ningbo 9
Norwalk 9
Rome 9
Cazzago San Martino 8
Hounslow 7
Toronto 7
Changchun 6
Fuzhou 6
Gunzenhausen 6
Kilburn 6
Skopje 6
Taiyuan 6
Islington 5
Kocaeli 5
Lappeenranta 5
Tokyo 5
Bergamo 4
Frankfurt am Main 4
Leawood 4
Monza 4
Piangipane 4
Prescot 4
Acton 3
Albino 3
Bari 3
Canberra 3
Gurugram 3
Markham 3
Milano 3
Montichiari 3
Orange 3
Oslo 3
Patras 3
Redmond 3
Rende 3
Wandsworth 3
Abbiategrasso 2
Braunschweig 2
Chicago 2
Chiswick 2
Corte 2
Council Bluffs 2
Cremona 2
Eskilstuna 2
Ferrara 2
Kandukur 2
Macerata 2
Magenta 2
Mantova 2
Totale 7.201
Nome #
Central airways remodeling in COPD patients 140
Il deficit di Alfa1-Anti-tripsina. 138
Methods for Measuring Lung Volumes: Is There a Better One? 116
Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: Effects of autonomic dysfunction improvement 114
Acute dynamic hyperinflation and systemic inflammation in stable COPD patients. 109
Vitamin D and health status in elderly. 109
Alpha1-antitrypsin deficiency-associated cervical artery dissection. Report of three cases. 107
Airway remodeling in allergen-challenged Brown Norway rats: Distribution of proteoglycans 106
Tidal airway closure during bronchoconstriction in asthma: usefulness of lung volume measurements. 105
Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea 102
Long-term physical training leads to airway remodelling in animal model. 99
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 97
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 95
Epatocirrosi e versamento pleurico recidivante (idotorace epatico). 94
Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients 93
The role of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 92
Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. 91
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 90
Diagnostic flow chart for targeted detection of alpha-1-antitrypsin deficiency 89
Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. 88
Diagnostic flow chart for targered detection of Alpha-1-antitrypsin deficiency. 88
Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. 86
Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction 86
Predictors of nocturnal oxyhemoglobin desaturation in COPD. 84
Dose-Response curve to salbutamol during acute and chronic treatment with formoterol in COPD. 84
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 82
Alpha1-Antitrypsin Deficiency in Spontaneous Cerebral Arterial Dissection. 78
Tidal airway closure in asthma and COPD 78
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments 78
Effect of PEEP on induced constriction is enhanced in decorin-deficient mice 77
Alpha1-antitrypsin deficiency. The Brescia (Italy) clinical study [Il deficit di alfa1-antitripsina: Lo studio clinico di Brescia] 76
Daytime approach to Obstructive Sleep Apnea phenotyping 76
Angiotensin II - receprot (AT1) blockade reduces ventricul arrhythimias in uncomplicated essential hypertensive patients. 74
Do GOLD stages of COPD severity really correspond to differences in health status? 73
Diagnostic flow chart for targeted detection of Alpha1-antitrypsin deficiency. 72
Dynamic pulmonary hyperinflation and low grade systemic inflammaton in stable COPD patients. 70
L'anziano di fronte ai problemi chirurgici: " I fattori di rischio" respiratori. 68
Alpha1-antitrypsin Deficiecy and nephropathy 67
Alpha1-antitrypsin deficiency and abdominal aortic aneurysms: does this association really exist? 66
Effect of training on airways inflammatory response and remodeling in a rat model. 65
Airway obstruction or closure during bronchoconstricction in asthma: can we preconize it? 65
Predictors of exercise-induced airways obstruction in patients with mild asthma 65
Early effects of CPAP on elastic aortic properties. 64
Consequences of SARS-COV-2 Pneumonia on Lung function 64
Deficit di Alfa1-antitripsina. 63
Alpha1-antitrypsin deficiency and arterial dissection: report of four cases 63
Phenotyping OSAH patients during wakefulness 63
Assessment of expiratory flow limitation in subjects with severe alpha-1-antitrypsin deficiency. 62
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 62
Alpha-1-antitrypsin deficiency - The Brescia Clinical Study. 61
ELASTIC PROPERTIES OF THE ASCENDING AORTA IN PATIENTS WITH ALPHA1-ANTITRYPSIN DEFICIENCY (Z-HOMOZYGOTES) 61
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 61
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 61
Role of respiratory mechanics in the pathogenesis of airway hyperresponsiveness in obese subject. 60
Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study 60
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 60
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool 60
Il deficit di alfa-1-antitripsina: lo studio clinico di Brescia. 59
Inhaled corticosteroids in COPD: Trying to make a long story short 59
Valutazione ecocardiografica in una popolazione di pazienti con deficit di alfa1-antitripsina (genotipo ZZ). 58
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 58
Alpha1-antitrypsin deficiency and asthma 57
Characteristics and treatment regimens across ERS SHARP severe asthma registries 56
ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE 56
Effect of precedine inspiratory speed and end-inspiratory on forced expiratory manoeuvre in healthy subjects and chronic obstructive pulmonary disease patients. 55
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 55
Dyspnea during night-time and at early morning in patients with stable copd is associated with supine tidal expiratory flow limitation 55
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy 55
COPD EXACERBATION AND AIRBORNE POLLUTANTS: CHARACTERIZING THE ROLE OF PARTICULATE MATTER AND FINE PARTICULATE MATTER SHORT-TERM EXPOSURE 55
Intra-epithelial polymerization, accumulation and secretion of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 54
Treatment of essential hypertension with hydrochlorothiazide combined with ACE-I or K+channel-I. 54
Assessment of expiratory flow limitation in subjects with severe alpha-1-Antitrypsin deficiency. alpha-1-antitrypsin deficiency - the biochemical basis of pulmonary emphysema. 54
Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry 54
COPD: It is time to change! 53
Effects of Chronic and Acute Pulmonary Hyperinflation on Phrenic Nerve Conduction in Patients with COPD 53
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 53
Alpha1-antitrypsin deficiency in spontaneous cerebral arterial dissection 52
Proprietà elastiche dell’aorta ascendente in una popolazione di pazienti con deficit di alfa1-antitripsina (genotipo ZZ). 52
Role of sighs and breathing pattern in the pathogenesis of airway hyperresponsiveness in healty obese subjects. 51
Respiratory mechanics in pathogenesis of AHR in obese subjects. 51
Vasodilators and diuretics control orthopnea also by reversing expiratory flow limitation in subjects with chronic heart failure. 51
A Six-Month Follow-Up Evaluation of Lung Function in Patients with Previous SARS-COV-2 Pneumonia 51
Severe alpha-1-antitrypsin deficiency : a cross-sectional clinical study. 49
Long-term physical trainign leads to airway remodelling in animal model. 49
Assessment of Small Airway Dysfunction and Z-Alpha1-Antitrypsin Polymers in Exhaled Breath Condensate in Healthy PiZZ Subjects 49
Emergency department visits for Asthma Exacerbation after short-term exposure to Particulate Matter: trend assessment in a European industrial city. 49
CHARACTERIZATION OF THE AIRWAY WALL COMPLIANCE AFTER TREATMENT WITH BRONCHODILATOR IN COPD PATIENTS 49
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 49
Long-term physical training leads to airway remodelling in animal model. 48
The role of exercise testing to assess the disability by silicosis in Italy. 48
In patients with bronchiectasis. is a casistis overview. 48
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 48
Time-Dependent Relationship Between Particulate Matter Exposure and COPD Exacerbations 48
Intermediate alpa1-antitrysin deficiency: A cross sectional clinical study. 47
Has cardio-pulmonary exercise testing a role in detecting early emphysema in alpha-1-antitrysin deficiency? 47
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? 47
Longitudinal Study of the Respiratory Function in Preterm Born Children: Comparison Between Subjects with and without Bronchopulmonary Dysplasia 47
CHARACTERIZATION OF THE IMPACT OF PARTICULATE MATTER AND FINE PARTICULATE MATTER ON ASTHMA EXACERBATION 47
Differences in proteoglycan deposition in the airway of moderate and severe asthmatics. 46
Intermediate alpha-1-antitrypsin deficiency: a cross-sectional clinical study. 46
Totale 6.879
Categoria #
all - tutte 56.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019251 0 0 0 0 0 0 0 0 0 54 106 91
2019/20201.677 352 31 33 186 55 173 182 176 61 264 36 128
2020/20212.202 71 166 53 197 197 268 100 243 295 238 238 136
2021/20221.469 68 168 46 165 29 101 55 132 95 175 123 312
2022/20231.326 208 109 60 88 85 320 2 177 134 6 44 93
2023/20241.438 69 25 156 164 86 426 56 88 362 6 0 0
Totale 10.100